BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 22863392)

  • 21. The diagnosis and management of malignant phaeochromocytoma and paraganglioma.
    Chrisoulidou A; Kaltsas G; Ilias I; Grossman AB
    Endocr Relat Cancer; 2007 Sep; 14(3):569-85. PubMed ID: 17914089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adverse drug reactions in patients with phaeochromocytoma: incidence, prevention and management.
    Eisenhofer G; Rivers G; Rosas AL; Quezado Z; Manger WM; Pacak K
    Drug Saf; 2007; 30(11):1031-62. PubMed ID: 17973541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MITOCHONDRIA: Succinate dehydrogenase subunit B-associated phaeochromocytoma and paraganglioma.
    Dona M; Neijman K; Timmers HJLM
    Int J Biochem Cell Biol; 2021 May; 134():105949. PubMed ID: 33609747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential expression of the regulated catecholamine secretory pathway in different hereditary forms of pheochromocytoma.
    Eisenhofer G; Huynh TT; Elkahloun A; Morris JC; Bratslavsky G; Linehan WM; Zhuang Z; Balgley BM; Lee CS; Mannelli M; Lenders JW; Bornstein SR; Pacak K
    Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1223-33. PubMed ID: 18854424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical manifestations of familial paraganglioma and phaeochromocytomas in succinate dehydrogenase B (SDH-B) gene mutation carriers.
    Srirangalingam U; Walker L; Khoo B; MacDonald F; Gardner D; Wilkin TJ; Skelly RH; George E; Spooner D; Monson JP; Grossman AB; Akker SA; Pollard PJ; Plowman N; Avril N; Berney DM; Burrin JM; Reznek RH; Kumar VK; Maher ER; Chew SL
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):587-96. PubMed ID: 18419787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The clinicopathological features and importance of p53, Rb, and mdm2 expression in phaeochromocytomas and paragangliomas.
    Lam KY; Lo CY; Wat NM; Luk JM; Lam KS
    J Clin Pathol; 2001 Jun; 54(6):443-8. PubMed ID: 11376017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phaeochromocytoma: diagnostic challenges for biochemical screening and diagnosis.
    Barron J
    J Clin Pathol; 2010 Aug; 63(8):669-74. PubMed ID: 20547690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumour risks and genotype-phenotype correlations associated with germline variants in succinate dehydrogenase subunit genes
    Andrews KA; Ascher DB; Pires DEV; Barnes DR; Vialard L; Casey RT; Bradshaw N; Adlard J; Aylwin S; Brennan P; Brewer C; Cole T; Cook JA; Davidson R; Donaldson A; Fryer A; Greenhalgh L; Hodgson SV; Irving R; Lalloo F; McConachie M; McConnell VPM; Morrison PJ; Murday V; Park SM; Simpson HL; Snape K; Stewart S; Tomkins SE; Wallis Y; Izatt L; Goudie D; Lindsay RS; Perry CG; Woodward ER; Antoniou AC; Maher ER
    J Med Genet; 2018 Jun; 55(6):384-394. PubMed ID: 29386252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phaeochromocytoma and Paraganglioma.
    Gunawardane PTK; Grossman A
    Adv Exp Med Biol; 2017; 956():239-259. PubMed ID: 27888488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phaeochromocytoma: state-of-the-art.
    Donckier JE; Michel L
    Acta Chir Belg; 2010; 110(2):140-8. PubMed ID: 20514823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Catecholamine secretion and ploidy in phaeochromocytoma.
    Tormey WP; Fitzgerald RJ; Thomas G; Kay EW; Leader MB
    Int J Clin Pract; 2000 Oct; 54(8):520-3. PubMed ID: 11198730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Report of a family with inherited medullary carcinoma of the thyroid and phaeochromocytoma.
    Beaugie JM; Belchetz PE; Brown CL; Frankel RJ; Lloyd MH
    Br J Surg; 1975 Apr; 62(4):264-8. PubMed ID: 1131504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased prevalence of catecholamine excess and phaeochromocytomas in a well-defined Dutch population with SDHD-linked head and neck paragangliomas.
    van Houtum WH; Corssmit EP; Douwes Dekker PB; Jansen JC; van der Mey AG; Bröcker-Vriends AH; Taschner PE; Losekoot M; Frölich M; Stokkel MP; Cornelisse CJ; Romijn JA
    Eur J Endocrinol; 2005 Jan; 152(1):87-94. PubMed ID: 15762191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current topics in pheochromocytoma.
    Nakao K; Itoh H; Takaya K
    Biomed Pharmacother; 2000 Jun; 54 Suppl 1():124s-128s. PubMed ID: 10915008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma-paraganglioma syndromes.
    Pasini B; Stratakis CA
    J Intern Med; 2009 Jul; 266(1):19-42. PubMed ID: 19522823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phaeochromocytoma.
    Lenders JW; Eisenhofer G; Mannelli M; Pacak K
    Lancet; 2005 Aug 20-26; 366(9486):665-75. PubMed ID: 16112304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phaeochromocytoma associated with cardiomyopathy and leukocytoclastic vasculitis in a dog.
    Poldy J; Gelendi S; Starybrat D; Del-Pozo J
    J Comp Pathol; 2023 Jul; 204():30-34. PubMed ID: 37329661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hereditary phaeochromocytoma in twins].
    Tóth G; Patócs A; Tóth M
    Orv Hetil; 2016 Aug; 157(33):1326-30. PubMed ID: 27523316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas.
    Benn DE; Croxson MS; Tucker K; Bambach CP; Richardson AL; Delbridge L; Pullan PT; Hammond J; Marsh DJ; Robinson BG
    Oncogene; 2003 Mar; 22(9):1358-64. PubMed ID: 12618761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pheochromocytoma of the adrenal gland selectively secreting dopamine -- a case report.
    Belowska-Bień K; Kucharski W; Janczak D; Urban J
    Endokrynol Pol; 2012; 63(5):391-7. PubMed ID: 23115074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.